Common Contracts

Contract

July 25th, 2017

• Filed
  July 25th, 2017

AMENDMENT 1 TO CONTRACT ON CLINICAL TRIAL DODATEK Č. 1 KE SMLOUVĚ O KLINICKÉM HODNOCENÍ This Amendment 1 to Contract On Clinical Trial (“Amendment”) is between Quintiles Czech Republic, s.r.o., with its seat at Radlická 714, 158 00 Praha 5, Czech Republic (“Quintiles” and/or “Contractual Research Organization” or “CRO”), Masarykůvonkologickýústav, having a place of business at Žlutýkopec 7, Brno, zip code 656 53, Czech Republic (the “Provider”), Astra Zeneca AB, having a place of business at 15185 Sӧdertӓlje, Sweden, SE-151 85 (the “Sponsor” and/or “Astra Zeneca”) and, an employee of the Provider, with the address at (the “Principal Investigator”), each a “Party” andtogether the “Parties” and is effective as of the date last signed below. Tento dodatek č. 1 ke smlouvě o klinickém hodnocení („Dodatek“) se uzavírá mezi Quintiles Czech Republic, s.r.o., se sídlem Radlická 714, 158 00 Praha 5, Česká republika („Quintiles“ nebo „smluvní výzkumná organizace“ nebo „CRO“), Masarykovým onko